- Concomitant inhibition of renin angiotensin system and Toll-like receptor 2 attenuates renal injury in unilateral ureteral obstructed mice
-
Chung S, Jeong JY, Chang YK, Choi DE, Na KR, Lim BJ, Lee KW
- KMID: 2373808
- Korean J Intern Med.
- 2016 Mar;31(2):323-334.
- doi: 10.3904/kjim.2015.004
BACKGROUND/AIMS: There has been controversy about the role of Toll-like receptor 2 (TLR2) in renal injury following ureteric obstruction. Although inhibition of the renin angiotensin system (RAS) reduces TLR2 expression... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography
-
Goo JJ, Kim JJ, Kang JH, Kim KN, Byun KS, Kim MK, Kim TI
- KMID: 1792036
- Korean J Intern Med.
- 2014 Mar;29(2):203-209.
- doi: 10.3904/kjim.2014.29.2.203
BACKGROUND/AIMS: With the increasing incidence of cardiovascular disease, angiocardiography using contrast-enhancing media has become an essential diagnostic and therapeutic tool, despite the risk of contrast-medium-induced acute kidney injury (CIAKI). CIAKI... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of RAAS Inhibition on the Incidence of Cancer and Cancer Mortality in Patients with Glomerulonephritis
-
Chin HJ, Oh SW, Goo HS, Oh J, Noh JW, Cho JT, Na KY, Kim S, Chae DW, Members of the PREMIER Group
- KMID: 1777977
- J Korean Med Sci.
- 2011 Jan;26(1):59-66.
- doi: 10.3346/jkms.2011.26.1.59
Angiotensin II type 1 receptor blocker (ARB), which is frequently prescribed in patients with glomerulonephritis (GN), is suggested to increase the risk of cancer. We registered 3,288 patients with renal... -
- CITED
-
- Close
- SHARE
-
- Close
- The Beneficial Effect of Renin-Angiotensin-Aldosterone System Blockade in Marfan Syndrome Patients after Aortic Root Replacement
-
Lee SJ, Oh J, Ko YG, Lee S, Chang BC, Lee DY, Kwak YR, Choi D
- KMID: 2466355
- Yonsei Med J.
- 2016 Jan;57(1):81-87.
- doi: 10.3349/ymj.2016.57.1.81
PURPOSE: In this study, we evaluated the long term beneficial effect of Renin-Angiotensin-Aldosterone System (RAAS) blockade therapy in treatment of Marfan aortopathy. MATERIALS AND METHODS: We reviewed Marfan syndrome (MFS) patients... -
- CITED
-
- Close
- SHARE
-
- Close
